Latest News
Spring 2026 Multi-Language Research Update
A message from Ricardo Ramírez, PhD, Chief Scientific Officer of The MED13L Foundation — with the latest updates on our progress and achievements. Now available! Get the latest update in…
MED13L Foundation Funds UCSF CRISPRa Study for MED13L Haploinsufficiency
Friday, December 5th, 2025 The MED13L Foundation is pleased to announce the execution of a Sponsored Research Agreement with the University of California, San Francisco (UCSF) to support a new…
Browse by Topic
MED13L Foundation to Launch Natural History Study of MED13L Syndrome with Boston Children’s Hospital
As featured in Brain & Life Magazine BOSTON, May 5, 2025 — The MED13L Foundation today announced a nearly $250,000 grant to help launch an innovative natural history study at…
Naproxen Shown to Upregulate MED13L.
One step closer to a therapeutic treatment. Could it be this easy? We Have a Hit! Rarebase Delivers. It’s not a home run, but a solid double from Rarebase! After…
Join us! World MED13L Syndrome Day 2023
Have you been wanting to get involved in the MED13L Foundation? Here is a great way! We are starting to plan for… World MED13L Syndrome Day – 2023 …and we…
December 2022 Office Hours
On December 6, 2022 Board Members Vanessa Dias and Katie Boychuck took some time to come into a zoom call and answer questions. It was a great success and we…
CURE MED13L Takes a Leap Forward
The Finding a Drug Discovery Partner (First) Edition of the Newsletter (10/17/21) Hello CURE MED13L Community! I’m Nick Seaver and this is the inaugural edition of the CURE MED13L newsletter. I can’t…












